![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
"About the advantages and disadvantages of discrete-event simulation for health economic analyses." Expert Review of Pharmacoeconomics & Outcomes Research, 16(6), pp. 651–652
Declaration of interest
M Toumi is Professor of Public Health at Aix Marseille University and is leading Creativ-Ceutical, a consultancy which develops Markov and discrete event simulation models and HTA applications. S Aballéa is an associate researcher at the Public Health department at the University of Aix-Marseille. E Beck, S Sherman, L Mohseninejad and S Aballéa are employees of Creativ-Ceutical. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
Notes
1. Currently a member of the NICE technology appraisal committee, not at the time when the article was published
Additional information
Funding
No funding was received for the work reported in this paper.